{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:41:29Z","timestamp":1792514489063,"version":"4.5.0"},"reference-count":53,"publisher":"AACN Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,15]]},"abstract":"<jats:p>Interstitial lung disease is a complex radiographic and histologic diagnosis, encompassing more than 200 disorders. Acute exacerbation presents as acute respiratory failure and mimics an upper respiratory viral syndrome. An extensive diagnostic workup is required to rule out other causes of acute respiratory failure and identify potential triggers. Treatment, including general supportive care and immunosuppression, depends on the underlying pathology. Respiratory support with high-flow nasal cannula should be initiated early in an attempt to minimize progression to invasive mechanical ventilation. Multidisciplinary conversations are vital to establish a care plan and outline candidacy for invasive mechanical ventilation, extracorporeal life support, and transplantation.<\/jats:p>","DOI":"10.4037\/aacnacc2025847","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:35:40Z","timestamp":1765308940000},"page":"374-388","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and Management of Acute Exacerbation of Interstitial Lung Disease in the Intensive Care Unit"],"prefix":"10.4037","volume":"36","author":[{"given":"Rebecca L.","family":"Rich","sequence":"first","affiliation":[{"name":"Rebecca L. Rich is Clinical Pharmacy Specialist, Critical Care and Pulmonary Services, Lakeland Regional Health, 1324 Lakeland Hills Blvd, Lakeland, FL 33805 (Rebecca.Rich@myLRH.org)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Peterson","sequence":"additional","affiliation":[{"name":"Amber Peterson is Advanced Practice Registered Nurse, Pulmonary Services, Lakeland Regional Health, Lakeland, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brown","sequence":"additional","affiliation":[{"name":"James Brown is Director, Center for Interstitial Lung Disease and Pulmonary Hypertension, Lakeland Regional Health, Lakeland, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"issue":"3","key":"2025120914353292500_b1-0360374","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5492\/wjccm.v12.i3.153","article-title":"Acute exacerbation of interstitial lung disease in the intensive care unit: principles of diagnostic evaluation and management","volume":"12","author":"Hayat Syed","year":"2023","journal-title":"World J Crit Care Med"},{"issue":"10","key":"2025120914353292500_b2-0360374","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/jcm13102956","article-title":"High-flow nasal cannula system in respiratory failure associated with interstitial lung diseases: a systematic review and narrative synthesis","volume":"13","author":"Pagliaro","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"2025120914353292500_b3-0360374","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5492\/wjccm.v11.i1.22","article-title":"Acute exacerbation of interstitial lung disease in the intensive care unit","volume":"11","author":"Charokopos","year":"2022","journal-title":"World J Crit Care Med"},{"issue":"2","key":"2025120914353292500_b4-0360374","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jemermed.2022.10.015","article-title":"Interstitial lung disease: a focused review for the emergency clinician","volume":"64","author":"Constantino","year":"2023","journal-title":"J Emerg Med"},{"issue":"9","key":"2025120914353292500_b5-0360374","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/resp.14763","article-title":"Steroid therapy in acute exacerbation of fibrotic interstitial lung disease","volume":"29","author":"Koshy","year":"2024","journal-title":"Respirology"},{"issue":"3","key":"2025120914353292500_b6-0360374","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"2025120914353292500_b7-0360374","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.3390\/jcm13226657","article-title":"The management of interstitial lung disease in the ICU: a comprehensive review","volume":"13","author":"Dhanani","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"2025120914353292500_b8-0360374","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ccm.2015.05.012","article-title":"Critically ill patients with interstitial lung disease","volume":"36","author":"Hadley","year":"2015","journal-title":"Clin Chest Med"},{"issue":"3","key":"2025120914353292500_b9-0360374","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults: an official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2025120914353292500_b10-0360374","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/ijms22020793","article-title":"Treatment of diffuse alveolar hemorrhage: controlling inflammation and obtaining rapid and effective hemostasis","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2025120914353292500_b11-0360374","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.chstcc.2023.100020","article-title":"ICU management of the patient with fibrotic interstitial lung disease","volume":"1","author":"Krishnan","year":"2023","journal-title":"CHEST Crit Care"},{"issue":"6","key":"2025120914353292500_b12-0360374","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000358443","article-title":"Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls","volume":"87","author":"Kawamura","year":"2014","journal-title":"Respiration"},{"issue":"3","key":"2025120914353292500_b13-0360374","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/thorax-2024-222636","article-title":"Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review","volume":"80","author":"Srivali","year":"2025","journal-title":"Thorax"},{"key":"2025120914353292500_b14-0360374","doi-asserted-by":"publisher","first-page":"17534666221117002","DOI":"10.1177\/17534666221117002","article-title":"Immunomodulatory treatment of interstitial lung disease","volume":"16","author":"van den Bosch","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"9","key":"2025120914353292500_b15-0360374","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"2025120914353292500_b16-0360374","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2025120914353292500_b17-0360374","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"Naccache","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"25","key":"2025120914353292500_b18-0360374","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"2025120914353292500_b19-0360374","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025120914353292500_b20-0360374","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2025120914353292500_b21-0360374","doi-asserted-by":"publisher","first-page":"157","DOI":"10.36141\/svdld.v36i2.7636","article-title":"Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases","volume":"36","author":"Schulze","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"2025120914353292500_b22-0360374","doi-asserted-by":"publisher","first-page":"e2021002","DOI":"10.36141\/svdld.v38i1.11271","article-title":"Cyclophosphamide for the treatment of acute exacerbation of interstitial lung disease: a review of the literature","volume":"38","author":"Innabi","year":"2021","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"6","key":"2025120914353292500_b23-0360374","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3899\/jrheum.131210","article-title":"Scleroderma renal crisis","volume":"41","author":"Mouthon","year":"2014","journal-title":"J Rheumatol"},{"issue":"6","key":"2025120914353292500_b24-0360374","doi-asserted-by":"publisher","first-page":"2202071","DOI":"10.1183\/13993003.02071-2022","article-title":"Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial","volume":"61","author":"Mankikian","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"2025120914353292500_b25-0360374","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1183\/09031936.00163911","article-title":"Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy","volume":"40","author":"Keir","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"2025120914353292500_b26-0360374","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.chest.2023.01.031","article-title":"Diagnosis and management of myositis-associated lung disease","volume":"163","author":"Hallowell","year":"2023","journal-title":"Chest"},{"issue":"10","key":"2025120914353292500_b27-0360374","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1513\/AnnalsATS.201603-179PS","article-title":"Intravenous immunoglobulin as potential adjunct therapy for interstitial lung disease","volume":"13","author":"Hallowell","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2025120914353292500_b28-0360374","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"2025120914353292500_b29-0360374","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis","volume":"151","author":"Morisset","year":"2017","journal-title":"Chest"},{"issue":"1","key":"2025120914353292500_b30-0360374","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jcm8010014","article-title":"Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study","volume":"8","author":"De Sadeleer","year":"2018","journal-title":"J Clin Med"},{"key":"2025120914353292500_b31-0360374","doi-asserted-by":"publisher","first-page":"106146","DOI":"10.1016\/j.rmed.2020.106146","article-title":"Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): a retrospective, multicentric, observational study","volume":"172","author":"Ferreira","year":"2020","journal-title":"Respir Med"},{"issue":"6","key":"2025120914353292500_b32-0360374","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"2025120914353292500_b33-0360374","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"2025120914353292500_b34-0360374","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1164\/rccm.201710-1967CI","article-title":"Acute eosinophilic pneumonia. Causes, diagnosis, and management","volume":"197","author":"De Giacomi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2025120914353292500_b35-0360374","doi-asserted-by":"publisher","first-page":"00209","DOI":"10.1183\/23120541.00209-2022","article-title":"Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan","volume":"8","author":"Urushiyama","year":"2022","journal-title":"ERJ Open Res"},{"issue":"7","key":"2025120914353292500_b36-0360374","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/CCM.0000000000004366","article-title":"Mechanical ventilation and predictors of in-hospital mortality in fibrotic interstitial lung disease with acute respiratory failure: a cohort analysis through the paradigm of acute respiratory distress syndrome","volume":"48","author":"Martin","year":"2020","journal-title":"Crit Care Med"},{"issue":"4","key":"2025120914353292500_b37-0360374","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000489890","article-title":"Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study","volume":"96","author":"Koyauchi","year":"2018","journal-title":"Respiration"},{"key":"2025120914353292500_b38-0360374","doi-asserted-by":"publisher","first-page":"1753466619847130","DOI":"10.1177\/1753466619847130","article-title":"High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis","volume":"13","author":"Vianello","year":"2019","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"2025120914353292500_b39-0360374","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18999\/nagjms.82.2.301","article-title":"High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study","volume":"82","author":"Omote","year":"2020","journal-title":"Nagoya J Med Sci"},{"issue":"1","key":"2025120914353292500_b40-0360374","doi-asserted-by":"publisher","first-page":"103","DOI":"10.21037\/jtd.2018.12.114","article-title":"Respiratory management of acute exacerbation of interstitial pneumonia using high-flow nasal cannula oxygen therapy: a single center cohort study","volume":"11","author":"Ito","year":"2019","journal-title":"J Thorac Dis"},{"issue":"4","key":"2025120914353292500_b41-0360374","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jcrc.2014.03.019","article-title":"Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis","volume":"29","author":"Vianello","year":"2014","journal-title":"J Crit Care"},{"issue":"15","key":"2025120914353292500_b42-0360374","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2169\/internalmedicine.49.3222","article-title":"Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"49","author":"Yokoyama","year":"2010","journal-title":"Intern Med"},{"issue":"14","key":"2025120914353292500_b43-0360374","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2169\/internalmedicine.49.3491","article-title":"Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia","volume":"49","author":"Tomii","year":"2010","journal-title":"Intern Med"},{"issue":"2","key":"2025120914353292500_b44-0360374","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1843.2011.02051.x","article-title":"Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia","volume":"17","author":"Yokoyama","year":"2012","journal-title":"Respirology"},{"issue":"1","key":"2025120914353292500_b45-0360374","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jtcvs.2013.06.039","article-title":"Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia","volume":"147","author":"Gaudry","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"2025120914353292500_b46-0360374","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.resinv.2023.01.008","article-title":"Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases","volume":"61","author":"Matsunashi","year":"2023","journal-title":"Respir Investig"},{"issue":"5","key":"2025120914353292500_b47-0360374","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1378\/chest.07-1481","article-title":"Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease","volume":"133","author":"Fern\u00e1ndez-P\u00e9rez","year":"2008","journal-title":"Chest"},{"issue":"5","key":"2025120914353292500_b48-0360374","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1164\/rccm.201508-1701OC","article-title":"Outcome of patients with interstitial lung disease treated with extracor-poreal membrane oxygenation for acute respiratory failure","volume":"193","author":"Trudzinski","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2025120914353292500_b49-0360374","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12931-021-01805-w","article-title":"Efficacy of extracorporeal membrane oxygenation for acute respiratory failure with interstitial lung disease: a case control nationwide dataset study in Japan","volume":"22","author":"Usagawa","year":"2021","journal-title":"Respir Res"},{"issue":"11","key":"2025120914353292500_b50-0360374","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2025120914353292500_b51-0360374","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1164\/rccm.202212-2342CI","article-title":"Progress in the treatment of pulmonary hypertension associated with interstitial lung disease","volume":"208","author":"Nathan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2025120914353292500_b52-0360374","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2025120914353292500_b53-0360374","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.rmed.2008.06.003","article-title":"Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit","volume":"102","author":"Mallick","year":"2008","journal-title":"Respir Med"}],"container-title":["AACN Advanced Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/36\/4\/374\/168067\/374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/36\/4\/374\/168067\/374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:35:51Z","timestamp":1765308951000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article\/36\/4\/374\/32914\/Diagnosis-and-Management-of-Acute-Exacerbation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12,15]]}},"URL":"https:\/\/doi.org\/10.4037\/aacnacc2025847","relation":{},"ISSN":["1559-7768","1559-7776"],"issn-type":[{"value":"1559-7768","type":"print"},{"value":"1559-7776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}